Michele Boldrin (University of Minnesota), David K. Levine (Los Angeles University of California)

Against Intellectual Monopoly

• Broschiertes Buch

Produktbeschreibung

This book examines patents and copyrights. It argues that these are not necessary for innovation and are detrimental to the common good, rather than beneficial. Unlike competing titles, the book has broad coverage of both copyrights and patents and is designed for a general audience, focusing on simple examples.

---

Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.

Produktdetails

• Verlag: Cambridge University Press
• Seitenzahl: 308
• Erscheinungstermin: 2. Mai 2017
• Englisch
• Abmessung: 229mm x 152mm x 17mm
• Gewicht: 466g
• ISBN-13: 9780521127264
• ISBN-10: 0521127262
• Artikelnr.: 28175991

Autorenporträt

Michele Boldrin is Joseph G. Hoyt Distinguished Professor of Economics in Arts and Sciences at Washington University in St Louis. He is a Fellow of the Econometric Society and a Research Fellow at the Centre for Economic Policy Research (London) and at FEDEA (Madrid). He is an Associate Editor of Econometrica, an Editor of the Review of Economic Dynamics, and an Advisory Editor of Macroeconomic Dynamics, published by Cambridge University Press. His research interests include growth, innovation, and business cycles; intergenerational and demographic issues; public policy; institutions; and social norms. He is the coauthor or coeditor of four books and has published in leading journals such as the American Economic Review, Econometrica, the Review of Economic Studies, the Journal of Political Economy, the Journal of Economic Theory, the Review of Economic Dynamics, the Journal of Monetary Economics, and the Journal of Economic Dynamics and Control.

Inhaltsangabe

1. Introduction
2. Creation under consumption
3. Innovation under competition
4. The evil of intellectual monopoly
5. The devil in Disney
6. How competition works
7. Defenses of intellectual monopoly
8. Does intellectual monopoly increase innovation?
9. The pharmaceutical industry
10. The bad, the good, and the ugly.